Checkpoint inhibitor monotherapy in potentially studyeligible or non-study-eligible NSCLC patients in the German CRISP Registry real-world cohort (AIO-TRK-0315).

3. Dezember 2022

F Griesinger; M Sebastian; W Brückl; H-D Hummel; B Jaeschke; J Kern; C Wesseler; M Jänicke; A Fleitz; S Zacharias; A Hipper; A Groth; W Weichert; S Dörfel; V Petersen; J Schröder; J Wilke; W E E Eberhardt; M Thomas, 2022.

Oncol Res Treat 2022;45(suppl 1):151

Download